FDA Registered 503B Outsourcing Facility


503B Compounding for Uncompromised Quality

Safer medications so you can prescribe with confidence.

Epicur Pharma™ brings a unique advantage to the veterinary industry. The 503B facility manufactures drugs with consistent potency, sterility, and purity from batch to batch.

A division of Stokes Healthcare and a sister company of Stokes Pharmacy, Epicur was developed in 2016 to align with the Food and Drug Administration’s (FDA) recommended guidelines and requirements for producing high-quality manufactured drugs. The 503B standards put in place reflect current Good Manufacturing Practices (cGMP), the same regulations in place for human pharmaceuticals.

Epicur Pharma is proud to be a pioneer in animal drug standards, offering the largest selection of manufactured drugs that are traditionally compounded. Our commitment to drug consistency and quality emphasizes our devotion to patient safety.

Epicur is proud to partner with and support AAHA in their commitment to continually raising the standard of care for companion animals. 

The Epicur Difference

Play Video

Get a glimpse of the quality processes that ensure every batch of your B products gets our A game.

Defining 503B

Play Video
Learn why 503B outsourcing facilities manufacture drugs according to Current Good Manufacturing Processes (cGMP).

Still have questions about 503B standards?